Sign in

Conagra Brands, Inc. CAG

Price 15.6 USD
as of 2026-09-04
32/100
Weak
Quality22
Growth10
Balance-sheet strength20
Valuation52
Momentum37
Income91

Composite 32/100; the shares have moved about 34% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Growth ranks 10/100 — a strong mark against it.

Case for

Income ranks 91/100 — a strong point in its favour. Valuation ranks 52/100 — a slight point in its favour.

Case against

Growth ranks 10/100 — a strong mark against it. Balance-sheet strength ranks 20/100 — a strong mark against it. Quality ranks 22/100 — a strong mark against it.

What the company does Conagra Brands (CAG) sells branded shelf-stable, refrigerated, frozen, and foodservice foods under brands such as Birds Eye, Duncan Hines, Healthy Choice, and Angie’s BOOMCHICKAPOP.

Key financials Margins are mixed: gross 24%, operating 13.8%, net –17.0%. ROE –25.1%, ROA 4.4%, ROCE –11.6%. Leverage is high (Debt/Equity 1.18, Net debt/EBITDA 4.17) with weak coverage (Interest coverage –4.26). Dividend yield is 8.2% with a 79.1% payout.

Stock health Quality and momentum are weak (Sideravia Overall 35.0), while income is strong (Income 89.3). Revenue growth is 3.6% and EPS growth 39.0%. RSI(14) is 58.50; stock is –23.40% below its 52-week high.

Price vs fair value CAG trades at a PREMIUM of 4.20% versus the analyst mean target of 14.38. - Investors bid up the stock after the dividend cut, citing potential margin relief (Motley Fool). - Analysts question whether low valuation offsets weak growth trends (Zacks). - Focus remains on Conagra’s fiscal 2027 pricing plan to ease margin pressure (Zacks).

Looking forward Fwd P/E is 10.64 and EV/EBITDA 14.98. Execution on pricing and cost management will determine whether the premium to fair value is justified.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.